• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络药理学的注射用总丹参酚酸对心肌缺血再灌注损伤潜在机制的分析

Network pharmacology-based analysis of potential mechanisms of myocardial ischemia-reperfusion injury by total salvianolic acid injection.

作者信息

Li Nan, Gu Xufang, Liu Fanqi, Zhang Yao, Sun Yanjun, Gao Shengwei, Wang Baohe, Zhang Chen

机构信息

Tianjin University of Chinese Medicine, Tianjin, China.

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.

出版信息

Front Pharmacol. 2023 Aug 23;14:1202718. doi: 10.3389/fphar.2023.1202718. eCollection 2023.

DOI:10.3389/fphar.2023.1202718
PMID:37680709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10482107/
Abstract

In this review, we investigated the potential mechanism of Total Salvianolic Acid Injection (TSI) in protecting against myocardial ischemia reperfusion injury (MI/RI). To achieve this, we predicted the component targets of TSI using Pharmmapper and identified the disease targets of MI/RI through GeneCards, DisGenNET, and OMIM databases. We constructed protein-protein interaction networks by analyzing the overlapping targets and performed functional enrichment analyses using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes. Our analysis yielded 90 targets, which were implicated in the potential therapeutic effects of TSI on MI/RI. Seven critical signaling pathways significantly contributed to TSI's protective effects, namely, PI3K signaling, JAK-STAT signaling, Calcium signaling, HIF-1 signaling, Nuclear receptor signaling, Cell Cycle, and Apoptosis. Subsequently, we conducted a comprehensive literature review of these seven key signaling pathways to gain further insights into their role in the TSI-mediated treatment of MI/RI. By establishing these connections, our study lays a solid foundation for future research endeavours to elucidate the molecular mechanisms through which TSI exerts its beneficial effects on MI/RI.

摘要

在本综述中,我们研究了注射用丹参总酚酸(TSI)预防心肌缺血再灌注损伤(MI/RI)的潜在机制。为此,我们使用Pharmmapper预测TSI的成分靶点,并通过GeneCards、DisGenNET和OMIM数据库确定MI/RI的疾病靶点。我们通过分析重叠靶点构建蛋白质-蛋白质相互作用网络,并使用基因本体论和京都基因与基因组百科全书进行功能富集分析。我们的分析产生了90个靶点,这些靶点与TSI对MI/RI的潜在治疗作用有关。七个关键信号通路对TSI的保护作用有显著贡献,即PI3K信号通路、JAK-STAT信号通路、钙信号通路、HIF-1信号通路、核受体信号通路、细胞周期和细胞凋亡。随后,我们对这七个关键信号通路进行了全面的文献综述,以进一步了解它们在TSI介导的MI/RI治疗中的作用。通过建立这些联系,我们的研究为未来阐明TSI对MI/RI发挥有益作用的分子机制的研究奠定了坚实的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/56a96fcb195d/fphar-14-1202718-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/cf1bf1939e79/fphar-14-1202718-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/2b36db7b3a62/fphar-14-1202718-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/2bcb0afba656/fphar-14-1202718-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/038c163b6993/fphar-14-1202718-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/5b06d81957e0/fphar-14-1202718-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/a1630e2fb722/fphar-14-1202718-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/1f78e9f517f6/fphar-14-1202718-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/56a96fcb195d/fphar-14-1202718-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/cf1bf1939e79/fphar-14-1202718-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/2b36db7b3a62/fphar-14-1202718-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/2bcb0afba656/fphar-14-1202718-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/038c163b6993/fphar-14-1202718-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/5b06d81957e0/fphar-14-1202718-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/a1630e2fb722/fphar-14-1202718-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/1f78e9f517f6/fphar-14-1202718-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dae/10482107/56a96fcb195d/fphar-14-1202718-g008.jpg

相似文献

1
Network pharmacology-based analysis of potential mechanisms of myocardial ischemia-reperfusion injury by total salvianolic acid injection.基于网络药理学的注射用总丹参酚酸对心肌缺血再灌注损伤潜在机制的分析
Front Pharmacol. 2023 Aug 23;14:1202718. doi: 10.3389/fphar.2023.1202718. eCollection 2023.
2
Exploring the Mechanism of Salvianolic Acid B against Myocardial Ischemia-Reperfusion Injury Based on Network Pharmacology.基于网络药理学探讨丹参酚酸B抗心肌缺血再灌注损伤的机制
Pharmaceuticals (Basel). 2024 Feb 28;17(3):309. doi: 10.3390/ph17030309.
3
Shuangshen Ningxin capsule alleviates myocardial ischemia-reperfusion injury in miniature pigs by modulating mitophagy: network pharmacology and experiments in vivo.双参宁心胶囊通过调节线粒体自噬减轻小型猪心肌缺血再灌注损伤:网络药理学及体内实验
Chin Med. 2023 Sep 20;18(1):120. doi: 10.1186/s13020-023-00810-z.
4
Uncovering the molecular mechanisms of Ilex pubescens against myocardial ischemia-reperfusion injury using network pharmacology analysis and experimental pharmacology.采用网络药理学分析和实验药理学方法揭示毛冬青对心肌缺血再灌注损伤的分子机制。
J Ethnopharmacol. 2022 Jan 10;282:114611. doi: 10.1016/j.jep.2021.114611. Epub 2021 Sep 17.
5
Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia/reperfusion injury with diabetes.基于网络药理学的舒心汤对糖尿病心肌缺血/再灌注损伤的保护作用及潜在机制研究
World J Diabetes. 2023 Jul 15;14(7):1057-1076. doi: 10.4239/wjd.v14.i7.1057.
6
Integrated chemical profiling, network pharmacology and pharmacological evaluation to explore the potential mechanism of Xinbao pill against myocardial ischaemia-reperfusion injury.综合化学分析、网络药理学和药理评价探讨心宝丸抗心肌缺血再灌注损伤的潜在机制。
Pharm Biol. 2022 Dec;60(1):255-273. doi: 10.1080/13880209.2022.2025859.
7
Anti-Myocardial Ischemia Reperfusion Injury Mechanism of Dried Ginger-Aconite Decoction Based on Network Pharmacology.基于网络药理学的干姜附子汤抗心肌缺血再灌注损伤机制研究
Front Pharmacol. 2021 May 6;12:609702. doi: 10.3389/fphar.2021.609702. eCollection 2021.
8
Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.基于网络药理学的芎黄方治疗缺血性中风的活性成分及作用机制预测与验证。
J Ethnopharmacol. 2023 Aug 10;312:116507. doi: 10.1016/j.jep.2023.116507. Epub 2023 Apr 18.
9
Network Pharmacology-Based Investigation and Experimental Exploration of the Antiapoptotic Mechanism of Colchicine on Myocardial Ischemia Reperfusion Injury.基于网络药理学的秋水仙碱对心肌缺血再灌注损伤抗凋亡机制的研究与实验探索
Front Pharmacol. 2021 Dec 16;12:804030. doi: 10.3389/fphar.2021.804030. eCollection 2021.
10
[Mechanism of Shenxiong Glucose Injection against myocardial ischemia-reperfusion injury based on network pharmacology and molecular docking].基于网络药理学和分子对接的参芎葡萄糖注射液抗心肌缺血再灌注损伤机制研究
Zhongguo Zhong Yao Za Zhi. 2022 May;47(10):2759-2766. doi: 10.19540/j.cnki.cjcmm.20211108.401.

引用本文的文献

1
Danqi soft capsules alleviate myocardial ischemia/reperfusion injury through inhibiting apoptosis-related signaling pathways.丹七软胶囊通过抑制凋亡相关信号通路减轻心肌缺血/再灌注损伤。
Am J Transl Res. 2025 Aug 15;17(8):6587-6600. doi: 10.62347/DODM6651. eCollection 2025.
2
Network Pharmacology Approaches to Myocardial Infarction Reperfusion Injury: Exploring Mechanisms, Pathophysiology, and Novel Therapies.心肌梗死再灌注损伤的网络药理学方法:探索机制、病理生理学及新疗法
Biomedicines. 2025 Jun 23;13(7):1532. doi: 10.3390/biomedicines13071532.
3
Therapeutic implications of endoplasmic reticulum stress gene CCL3 in cervical squamous cell carcinoma.

本文引用的文献

1
Network Pharmacology Analyses of the Pharmacological Targets and Therapeutic Mechanisms of Salvianolic Acid A in Myocardial Infarction.丹参酸A治疗心肌梗死的药理靶点及作用机制的网络药理学分析
Evid Based Complement Alternat Med. 2022 Oct 5;2022:8954035. doi: 10.1155/2022/8954035. eCollection 2022.
2
LincRNA-p21 Upregulates Nuclear Orphan Receptor Nr4a2 and Aggravates Myocardial Ischemia/Reperfusion Injury via Targeting MiR-466i-5p.长链非编码 RNA-p21 通过靶向 miR-466i-5p 上调核孤儿受体 Nr4a2 并加重心肌缺血/再灌注损伤。
Int Heart J. 2022;63(5):1004-1014. doi: 10.1536/ihj.21-856.
3
Clinical Patterns of Traditional Chinese Medicine for Ischemic Heart Disease Treatment: A Population-Based Cohort Study.
内质网应激基因CCL3在宫颈鳞状细胞癌中的治疗意义
Cell Biol Toxicol. 2025 Feb 20;41(1):47. doi: 10.1007/s10565-024-09949-3.
4
Network pharmacology: a crucial approach in traditional Chinese medicine research.网络药理学:中医药研究的关键方法。
Chin Med. 2025 Jan 12;20(1):8. doi: 10.1186/s13020-024-01056-z.
基于人群队列研究的中医药治疗缺血性心脏病的临床模式。
Medicina (Kaunas). 2022 Jun 30;58(7):879. doi: 10.3390/medicina58070879.
4
JCS 2022 Guideline Focused Update on Diagnosis and Treatment in Patients With Stable Coronary Artery Disease.《日本循环学会2022年稳定性冠状动脉疾病患者诊断与治疗指南重点更新》
Circ J. 2022 Apr 25;86(5):882-915. doi: 10.1253/circj.CJ-21-1041. Epub 2022 Mar 11.
5
The nuclear receptor co-repressor 1 is a novel cardioprotective factor against acute myocardial ischemia-reperfusion injury.核受体共抑制因子1是一种针对急性心肌缺血-再灌注损伤的新型心脏保护因子。
J Mol Cell Cardiol. 2022 May;166:50-62. doi: 10.1016/j.yjmcc.2022.01.006. Epub 2022 Jan 23.
6
Mechanism research of Salvia miltiorrhiza on treating myocardial ischemia reperfusion injury according to network pharmacology combined with molecular docking technique.基于网络药理学结合分子对接技术研究丹参治疗心肌缺血再灌注损伤的作用机制。
Medicine (Baltimore). 2021 Dec 3;100(48):e28132. doi: 10.1097/MD.0000000000028132.
7
Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.右美托咪定通过 p53 和叉头框 O3a(FOXO3a)/p53 上调凋亡调节因子(PUMA)信号通路减轻缺血再灌注诱导的心肌细胞损伤。
Bioengineered. 2022 Jan;13(1):1377-1387. doi: 10.1080/21655979.2021.2017611.
8
Piperine protects against myocardial ischemia/reperfusion injury by activating the PI3K/AKT signaling pathway.胡椒碱通过激活PI3K/AKT信号通路来保护心肌缺血/再灌注损伤。
Exp Ther Med. 2021 Apr;21(4):374. doi: 10.3892/etm.2021.9805. Epub 2021 Feb 19.
9
Elabela alleviates myocardial ischemia reperfusion-induced apoptosis, fibrosis and mitochondrial dysfunction through PI3K/AKT signaling.埃拉贝拉通过PI3K/AKT信号通路减轻心肌缺血再灌注诱导的细胞凋亡、纤维化和线粒体功能障碍。
Am J Transl Res. 2020 Aug 15;12(8):4467-4477. eCollection 2020.
10
Modulatory Effects of Chinese Herbal Medicines on Energy Metabolism in Ischemic Heart Diseases.中药对缺血性心脏病能量代谢的调节作用
Front Pharmacol. 2020 Jul 3;11:995. doi: 10.3389/fphar.2020.00995. eCollection 2020.